Reconstruction of Long-Chain Polyunsaturated Acid Synthesis Pathways in Marine Red Microalga Porphyridium cruentum Using Lipidomics and Transcriptomics
Marine Drugs · 2024
DOI: 10.3390/md22020082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Tao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Tropical Marine Bio-Resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, Institution of South China Sea Ec…. Hauptthemen laut MEDLINE: Porphyridium, Microalgae. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and applied Basic Research Foundation, Basic and applied Basic Research Foundation, the Marine Economic Development Project.
Abstract (Originalsprache)
The marine red microalga Porphyridium can simultaneously synthesize long-chain polyunsaturated fatty acids, including eicosapentaenoic acid (C20:5, EPA) and arachidonic acid (C20:4, ARA). However, the distribution and synthesis pathways of EPA and ARA in Porphyridium are not clearly understood. In this study, Porphyridium cruentum CCALA 415 was cultured in nitrogen-replete and nitrogen-limited conditions. Fatty acid content determination, transcriptomic, and lipidomic analyses were used to investigate the synthesis of ARA and EPA. The results show that membrane lipids were the main components of lipids, while storage lipids were present in a small proportion in CCALA 415. Nitrogen limitation enhanced the synthesis of storage lipids and ω6 fatty acids while inhibiting the synthesis of membrane lipids and ω3 fatty acids. A total of 217 glycerolipid molecular species were identified, and the most abundant species included monogalactosyldiglyceride (C16:0/C20:5) (MGDG) and phosphatidylcholine (C16:0/C20:4) (PC). ARA was mainly distributed in PC, and EPA was mainly distributed in MGDG. Among all the fatty acid desaturases (FADs), the expressions of Δ5FAD, Δ6FAD, Δ9FAD, and Δ12FAD were up-regulated, whereas those of Δ15FAD and Δ17FAD were down-regulated. Based on these results, only a small proportion of EPA was synthesized through the ω3 pathway, while the majority of EPA was synthesized through the ω6 pathway. ARA synthesized in the ER was likely shuttled into the chloroplast by DAG and was converted into EPA by Δ17FAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Tropical Marine Bio-Resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, Institution of South China Sea Ecology and Environmental Engineering, South China Sea Institute of Ocea…
- Guangzhou Institute of Energy Conversion, Chinese Academy of Sciences, CAS Key Laboratory of Renewable Energy, Guangdong Provincial Key Laboratory of New and Renewable Energy Research and Development, Guangzhou 510640,…
ORCID-Profile: Chulin Li, Weinan Wang, Wenzhou Xiang
Förderung
- Guangdong Basic and applied Basic Research Foundation
- Basic and applied Basic Research Foundation
- the Marine Economic Development Project
- Marine Economic Development Project
Zitieren
APA
Li, T., Li, C., Wang, W., Wu, H., Wu, H., Xu, J., & Xiang, W. (2024). Reconstruction of Long-Chain Polyunsaturated Acid Synthesis Pathways in Marine Red Microalga Porphyridium cruentum Using Lipidomics and Transcriptomics. Marine Drugs. https://doi.org/10.3390/md22020082
Vancouver
Li T, Li C, Wang W, Wu H, Wu H, Xu J, et al. Reconstruction of Long-Chain Polyunsaturated Acid Synthesis Pathways in Marine Red Microalga Porphyridium cruentum Using Lipidomics and Transcriptomics. Marine Drugs. 2024. doi:10.3390/md22020082
BibTeX
@article{Li2024,
author = {Li, Tao and Li, Chulin and Wang, Weinan and Wu, Hualian and Wu, Houbo and Xu, Jin and Xiang, Wenzhou},
title = {Reconstruction of Long-Chain Polyunsaturated Acid Synthesis Pathways in Marine Red Microalga Porphyridium cruentum Using Lipidomics and Transcriptomics},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22020082}
}
EUVIMED